ArticleJAAD case reports2024

Amivantamab, the first epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with penile and inguinal ulcers and paronychia.

Karina J Cancel-Artau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.